文献速递糖尿病

无妊娠糖尿病女性的早孕期中间型高血糖与不良妊娠结局

Early-Pregnancy Intermediate Hyperglycemia and Adverse Pregnancy Outcomes Among Women Without Gestational Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该回顾性队列研究纳入2013至2017年上海妇产科医院24 479例单胎妊娠,分析早孕期空腹血糖5.1-6.9 mM且后续口服葡萄糖耐量试验正常者的妊娠结局,发现中间型高血糖组的大于胎龄儿、首次剖宫产、早产、子痫前期和新生儿窘迫发生率显著更高。

要点

  • 早孕期空腹血糖5.1-6.9 mM且后续OGTT正常者,首次剖宫产风险仍升高(AOR 1.24)。
  • 该组早产风险升高(AOR 1.75),新生儿窘迫风险升高(AOR 3.29)。
  • 即使后续OGTT正常,早孕期中间型高血糖仍与不良母胎结局相关。

核心结论

  • 早孕期中间型高血糖女性即使后续OGTT正常,仍面临不良母胎结局风险增加。

研究设计与样本

  • 回顾性队列研究,2013至2017年于中国上海妇产科医院开展。
  • 纳入早孕期空腹血糖≤6.9 mM并接受75-g OGTT的单胎妊娠,排除孕前糖尿病,共24 479例分娩。
  • 其中23 450例(95.8%)后续OGTT正常,807例(3.4%)早孕期空腹血糖5.1-6.9 mM。
  • 分析后续OGTT正常者中早孕期空腹血糖<5.1 mM组(N=20692)与中间型高血糖组(N=693)的妊娠结局。
  • 采用多因素logistic回归,统计显著性定义为P<.05。

主要发现

  • 中间型高血糖组年龄和BMI高于空腹血糖<5.1 mM组,大于胎龄儿、首次剖宫产、早产、子痫前期和新生儿窘迫发生率显著更高。
  • 调整母亲年龄、BMI及其他潜在混杂因素后,首次剖宫产(AOR 1.24;95% CI,1.05-1.45)、早产(AOR 1.75;95% CI,1.29-2.36)和新生儿窘迫(AOR 3.29;95% CI,1.57-6.89)仍统计学显著更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Universal early-pregnancy screening for overt diabetes reveals intermediate hyperglycemia (fasting plasma glucose [FPG] [5.1-6.9 mM]). OBJECTIVE: We evaluated the association between early-pregnancy intermediate hyperglycemia and adverse pregnancy outcomes among women without gestational diabetes. METHODS: This retrospective cohort study was conducted at the Obstetrics and Gynecology Hospital, Shanghai, China, from 2013 to 2017. All singleton pregnancies with FPG less than or equal to 6.9 mM in early pregnancy and receiving a 75-g oral glucose tolerance test (OGTT) were included. Women with prepregnancy diabetes were excluded. Individuals with normal OGTT were analyzed. Pregnancy outcomes for FPG less than 5.1 mM and intermediate hyperglycemia were evaluated. The primary outcomes were large for gestational age (LGA) and primary cesarean delivery. Multivariate logistic regressions were conducted. Statistical significance was defined as P less than .05. RESULTS: In total, 24 479 deliveries were included, of which 23 450 (95.8%) had normal OGTTs later in pregnancy (NGT). There were 807 (3.4%) women who had an FPG of 5.1 to 6.9 mM in early pregnancy. Compared to the NGT group with an FPG of less than 5.1 mM in early pregnancy (N = 20692), the intermediate hyperglycemia NGT group (N = 693) had a higher age and body mass index (BMI), and significantly higher rates of LGA, primary cesarean delivery, preterm birth, preeclampsia, and neonatal distress. The rates of primary cesarean delivery (adjusted odds ratio [AOR] 1.24; 95% CI, 1.05-1.45), preterm birth (AOR 1.75; 95% CI, 1.29-2.36), and neonatal distress (AOR 3.29; 95% CI, 1.57-6.89) remained statistically significantly higher after adjustments for maternal age, BMI, and other potential confounding factors. CONCLUSION: Women with intermediate hyperglycemia in early pregnancy are at an increased risk for adverse maternal-fetal outcomes, even with normal future OGTTs.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ye Y, Xiong Y, Zhou Q, et al. Early-Pregnancy Intermediate Hyperglycemia and Adverse Pregnancy Outcomes Among Women Without Gestational Diabetes. J Clin Endocrinol Metab. 2022. PMID: 34850011. doi:10.1210/clinem/dgab841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。